Full Text View
Tabular View
No Study Results Posted
Related Studies
Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002 AM1)
This study is ongoing, but not recruiting participants.
Study NCT01254604   Information provided by Merck

First Received on December 3, 2010.   Last Updated on April 19, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glaucoma
Ocular Hypertension
Additional conditions recognized in this trial
Glaucoma, Open-Angle
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Eye Diseases
Vascular Diseases
Interventions listed in this trial
Preservative-Free Timolol maleate
Additional drug interventions recognized in this trial
Maleic acid
Timolol
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services